Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan

Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan

We reported 25 recipients (14 females and 11 males) aged from 18 to 65 years who unexpectedly received a primary dose of undiluted BNT162b2 vaccine (180 μg). The most common adverse reactions included injection site pain (n = 22), followed by fever (9), fatigue (8), chest tightness (6), and dizzines...

Full description

Bibliographic Details
Main Authors: Wang-Huei Sheng, Chung-Cheng Wang, Ching-Chi Chu, Yueh-Juh Lin, Sui-Yuan Chang, Si-Man Ieong, Shan-Chwen Chang
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Journal of the Formosan Medical Association
Subjects:
Coronavirus disease 2019 (COVID-19)
Undiluted BNT162b2 vaccine
Adverse events
Immune response
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664622002820

Similar Items

Similar Items